Cargando…
Leveraging Affinity Interactions to Prolong Drug Delivery of Protein Therapeutics
While peptide and protein therapeutics have made tremendous advances in clinical treatments over the past few decades, they have been largely hindered by their ability to be effectively delivered to patients. While bolus parenteral injections have become standard clinical practice, they are insuffic...
Autores principales: | Dogan, Alan B., Dabkowski, Katherine E., von Recum, Horst A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144912/ https://www.ncbi.nlm.nih.gov/pubmed/35631672 http://dx.doi.org/10.3390/pharmaceutics14051088 |
Ejemplares similares
-
Polymer Additives to Personal Protective Equipment can Inactivate Pathogens
por: Dogan, Alan B., et al.
Publicado: (2022) -
Polymer Microparticles Prolong Delivery of the 15-PGDH Inhibitor SW033291
por: Dogan, Alan B., et al.
Publicado: (2021) -
Affinity Effects on the Release of Non-Conventional Antifibrotics from Polymer Depots
por: Rohner, Nathan A., et al.
Publicado: (2020) -
Erythromycin Modification That Improves Its Acidic Stability while Optimizing It for Local Drug Delivery
por: Cyphert, Erika L., et al.
Publicado: (2017) -
Elucidating the Structure-Function Relationship of Solvent and Cross-Linker on Affinity-Based Release from Cyclodextrin Hydrogels
por: Zuckerman, Sean T., et al.
Publicado: (2020)